Advanced search
Publication Cover
Modern Rheumatology Volume 26, 2016 - Issue 6
Journal homepage
420
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study

Hidekazu IkeuchiDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Keiju HiromuraDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, JapanCorrespondence[email protected]
,
Ken KayakabeDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Kadiombo Anastasie TshilelaDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Kazuhiko UchiyamaDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Hiroko HamataniDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Toru SakairiDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Yoriaki KanekoDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
,
Akito MaeshimaDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
&
Yoshihisa NojimaDepartment of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Gunma, Japan
 show all
Pages 908-913 | Received 03 Sep 2015, Accepted 20 Feb 2016, Published online: 26 Apr 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yusuke Okabayashi, Nobuo Tsuboi, Kotaro Haruhara, Go Kanzaki, Kentaro Koike, Yoichi Miyazaki, Tetsuya Kawamura, Makoto Ogura & Takashi Yokoo. (2020) Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV. Modern Rheumatology 30:1, pages 125-131.
Read now
Yuka Shimizu, Shinsuke Yasuda, Taichi Kimura, Saori Nishio, Michihiro Kono, Kazumasa Ohmura, Sanae Shimamura, Michihito Kono, Yuichiro Fujieda, Masaru Kato, Kenji Oku, Toshiyuki Bohgaki, Yuichiro Fukasawa, Shinya Tanaka & Tatsuya Atsumi. (2018) Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment. Modern Rheumatology 28:4, pages 661-669.
Read now

Articles from other publishers (11)

Satyesh K. Sinha, Michael Mellody, Maria Beatriz Carpio, Robert Damoiseaux & Susanne B. Nicholas. (2023) Osteopontin as a Biomarker in Chronic Kidney Disease. Biomedicines 11:5, pages 1356.
Crossref
Hidekazu Ikeuchi, Hitoshi Sugiyama, Hiroshi Sato, Hitoshi Yokoyama, Shoichi Maruyama, Masashi Mukoyama, Hiroki Hayashi, Tatsuo Tsukamoto, Michio Fukuda, Kunihiro Yamagata, Eiji Ishikawa, Keiko Uchida, Yuji Kamijo, Naoki Nakagawa, Kazuhiko Tsuruya, Yoshihisa Nojima & Keiju Hiromura. (2022) A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan. Clinical and Experimental Nephrology 26:9, pages 898-908.
Crossref
Sung Soo Ahn, Juyoung Yoo, Sang-Won Lee, Jason Jungsik Song, Yong-Beom Park & Seung Min Jung. (2022) Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience. Lupus 31:5, pages 588-595.
Crossref
Momoko Okamoto, Mineaki Kitamura, Shuntaro Sato, Keita Fujikawa, Yoshiro Horai, Naoki Matsuoka, Masahiko Tsuboi, Fumiaki Nonaka, Toshimasa Shimizu, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Tomoya Nishino, Atsushi Kawakami & Kunihiro Ichinose. (2021) Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis. Rheumatology 60:5, pages 2333-2341.
Crossref
Ryosuke Umeda, Soshiro Ogata, Shigeo Hara, Kazuo Takahashi, Daijo Inaguma, Midori Hasegawa, Hidetaka Yasuoka, Yukio Yuzawa, Hiroki Hayashi & Naotake Tsuboi. (2020) Comparison of the 2018 and 2003 International Society of Nephrology/Renal Pathology Society classification in terms of renal prognosis in patients of lupus nephritis: a retrospective cohort study. Arthritis Research & Therapy 22:1.
Crossref
Kunihiro Ichinose, Mineaki Kitamura, Shuntaro Sato, Keita Fujikawa, Yoshiro Horai, Naoki Matsuoka, Masahiko Tsuboi, Fumiaki Nonaka, Toshimasa Shimizu, Remi Sumiyoshi, Tomohiro Koga, Shin-ya Kawashiri, Naoki Iwamoto, Takashi Igawa, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Tomoya Nishino & Atsushi Kawakami. (2020) Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort. Arthritis Research & Therapy 22:1.
Crossref
Filipa Farinha, Ruth J Pepper, Daniel G Oliveira, Thomas McDonnell, David A Isenberg & Anisur Rahman. (2020) Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up. Rheumatology 59:11, pages 3314-3323.
Crossref
Beata Kaleta. (2018) The role of osteopontin in kidney diseases. Inflammation Research 68:2, pages 93-102.
Crossref
Cynthia C. Lim, Hui Z. Tan, Ying Hao, Yok M. Chin, Keng T. Woo, Choong M. Chan & Jason C. J. Choo. (2018) Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study. Internal Medicine Journal 48:9, pages 1117-1123.
Crossref
Hironari Hanaoka, Harunobu Iida, Tomofumi Kiyokawa, Yukiko Takakuwa, Takahiro Okazaki, Hidehiro Yamada, Shoichi Ozaki & Kimito Kawahata. (2018) Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome. PLOS ONE 13:5, pages e0196172.
Crossref
Laurent Arnaud & Ronald van VollenhovenLaurent Arnaud & Ronald van Vollenhoven. 2018. Advanced Handbook of Systemic Lupus Erythematosus. Advanced Handbook of Systemic Lupus Erythematosus 39 70 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.